An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma. Zhang W, Li Y, Lyu J, Shi F, et al. Cancer Sci 2022;113:891-903.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang W, Li Y, Lyu J, Shi F, et al. An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma. Cancer Sci 2022;113:891-903.
PMID: 34967077